This page contains exclusive content for the member of the following sections: TTS, CTS, IPITA, ISODP, IXA, ITA, TID, IHCTAS, IPTA. Log in to view.
Kidney I: Immunosuppression
201.1 - Efficacy and safety of everolimus with reduced tacrolimus and early steroid elimination regimen in de novo pediatric renal transplant recipients: 12-month data from the CRADLE study
Presenter: Burkhard, Toenshoff, Heidelberg, Germany Authors: Burkhard Tönshoff, Robert Ettenger, Lars Pape, Luca Dello Strologo, El-Djouher Martzloff, Barbara Rauer, Jennifer Ng, Patricia Lopez, Anna Bjerre, Martin Christian, Stephen Marks
By viewing the material on this site you understand and
The opinions and statements expressed on this site reflect the
views of the author or authors and do not necessarily reflect those of
The Transplantation Society and/or its Sections.
The hosting of material on The Transplantation Society site does
not signify endorsement of this material by The Transplantation Society
and/or its Sections.
The material is solely for educational purposes for qualified
health care professionals.
The Transplantation Society and/or its Sections are not liable for
any decision made or action taken based on the information contained in
the material on this site.
The information cannot be used as a substitute for professional
The information does not represent a standard of care.
No physician-patient relationship is being established.